Found: 25
Select item for more details and to access through your institution.
Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 6, p. e2418486, doi. 10.1001/jamanetworkopen.2024.18486
- By:
- Publication type:
- Article
Survival outcomes of patients with HER2/neu‐positive breast cancer with germline BRCA mutations.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1600, doi. 10.1002/cncr.35159
- By:
- Publication type:
- Article
Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.
- Published in:
- European Journal of Breast Health, 2023, v. 19, n. 4, p. 267, doi. 10.4274/ejbh.galenos.2023.2023-7-3
- By:
- Publication type:
- Article
Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 3, p. 1663, doi. 10.1245/s10434-022-12468-2
- By:
- Publication type:
- Article
Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences.
- Published in:
- Breast Journal, 2022, v. 2022, p. 1, doi. 10.1155/2022/1447545
- By:
- Publication type:
- Article
Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00407-z
- By:
- Publication type:
- Article
Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 6, p. 1474, doi. 10.1002/cam4.4566
- By:
- Publication type:
- Article
Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 12, p. 4613, doi. 10.1245/s10434-020-08889-6
- By:
- Publication type:
- Article
Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.
- Published in:
- Breast Journal, 2020, v. 26, n. 8, p. 1572, doi. 10.1111/tbj.13922
- By:
- Publication type:
- Article
Prospective Evaluation of Universal BRCA Testing for Women With Triple-Negative Breast Cancer.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkaa002
- By:
- Publication type:
- Article
Elevated serum levels of sialyl Lewis X (sLe<sup>X</sup>) and inflammatory mediators in patients with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 3, p. 545, doi. 10.1007/s10549-019-05258-0
- By:
- Publication type:
- Article
Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 6, p. 2718, doi. 10.1002/cam4.1519
- By:
- Publication type:
- Article
Reply to Diagnosis of patients with inflammatory breast cancer is a problematic issue.
- Published in:
- 2018
- By:
- Publication type:
- letter
BRCA mutations in women with inflammatory breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomes.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 11, p. 2515, doi. 10.1002/cam4.1207
- By:
- Publication type:
- Article
Evaluation of BRCAPRO Risk Assessment Model in Patients with Ductal Carcinoma In situ Who Underwent Clinical BRCA Genetic Testing.
- Published in:
- Frontiers in Genetics, 2016, p. 1, doi. 10.3389/fgene.2016.00071
- By:
- Publication type:
- Article
High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells.
- Published in:
- International Journal of Oncology, 2015, v. 47, n. 1, p. 262, doi. 10.3892/ijo.2015.3003
- By:
- Publication type:
- Article
Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.
- Published in:
- Breast Journal, 2015, v. 21, n. 3, p. 260, doi. 10.1111/tbj.12392
- By:
- Publication type:
- Article
Predictors that Influence Contralateral Prophylactic Mastectomy Election Among Women with Ductal Carcinoma In Situ Who Were Evaluated for BRCA Genetic Testing.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 10, p. 3466, doi. 10.1245/s10434-014-3747-x
- By:
- Publication type:
- Article
Genotype in BRCA-associated Breast Cancers.
- Published in:
- Breast Journal, 2013, v. 19, n. 1, p. 87, doi. 10.1111/tbj.12056
- By:
- Publication type:
- Article
Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Predictive factors for BRCA1/ BRCA2 mutations in women with ductal carcinoma in situ.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 6, p. 1515, doi. 10.1002/cncr.26428
- By:
- Publication type:
- Article
Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 4, p. 908, doi. 10.1002/cncr.26377
- By:
- Publication type:
- Article
Cancer Risk Management Decisions of Women with BRCA1 or BRCA2 Variants of Uncertain Significance.
- Published in:
- Breast Journal, 2011, v. 17, n. 2, p. 210, doi. 10.1111/j.1524-4741.2010.01055.x
- By:
- Publication type:
- Article